Advertisement
Screener

Longevity Health Holdings, Inc. (XAGE) EBITDA

Longevity Health Holdings, Inc. (XAGE) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$710.81K*; Operating income -$724.15K; Depreciation and amortization $13.34K*.
  • 2026-03-31: Basis Reported; EBITDA -$1.31M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$2.25M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$1.45M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2022-09-30 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$710.81K*-$724.15K$13.34K*$395.99K-179.50%*(m)-$223.88K*$160.46K$73.35K(m)$0.00
2026-03-31Reported-$1.31M(m)(m)(m)-335.27%(m)-$485.29K$154.74K$55.49K(m)$0.00
2025-12-31Reported-$2.25M(m)(m)(m)-476.75%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$1.45M(m)(m)(m)-341.60%(m)-$1.43M*$171.40K$227.99K(m)$0.00
2025-06-30Reported-$1.84M(m)(m)(m)-364.65%(m)-$836.19K*$200.95K$228.61K(m)$0.00
2025-03-31Reported-$1.48M(m)(m)(m)-290.54%(m)-$752.95K$240.53K$196.91K(m)$0.00
2024-12-31Reported-$988,430.00(m)(m)(m)-5654.96%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$1.4M(m)(m)(m)-6831.77%(m)-$906.94K*$4.84K$331.81K(m)$0.00
2024-06-30Reported-$1.17M(m)(m)(m)-9480.17%(m)-$1.14M*$292.00$104.07K(m)$0.00
2024-03-31Reported-$1.36M(m)(m)(m)(m)(m)-$1.08M$0.00$429.42K(m)$0.00
2023-12-31Reported-$309,436.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$2.83M(m)(m)(m)(m)$0.00*-$3.98M*$0.00$1.59M(m)$0.00
2023-06-30Reported-$1.46M(m)(m)(m)(m)(m)-$480.18K*$0.00$823.66K(m)$0.00
2023-03-31Reported-$1.25M(m)(m)(m)(m)(m)-$475.96K(m)$740.33K(m)$0.00
2022-12-31Reported-$2.76M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$828,304.00(m)(m)(m)(m)(m)-$934.63K*$0.00$570.93K(m)$0.00
2022-06-30Reported(m)-$285.88K(m)(m)(m)(m)-$43.24K*(m)(m)(m)$266.41K
2022-03-31Reported(m)-$535.14K(m)(m)(m)(m)-$151.67K(m)(m)(m)$0.00
2021-09-30Reported(m)-$89.96K(m)(m)(m)(m)-$373.88K*(m)(m)(m)$0.00
2021-06-30Reported(m)-$6.37K(m)(m)(m)(m)(m)(m)(m)(m)$0.00
2021-03-31Reported(m)-$1.21K(m)(m)(m)(m)(m)(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$7.03M(m)(m)(m)-367.46%$14.22K-$3.33M$818.05K$788.89K(m)$36.26K
2024-12-31Reported-$4.92M(m)(m)(m)-9767.90%(m)-$3.89M$6.36K$1.05M(m)-$97.28K
2023-12-31Reported-$5.85M(m)(m)(m)(m)$30.47K-$8.35M$0.00$2.50M(m)$0.00
2022-12-31Reported-$5.41M(m)(m)(m)(m)$7.16K-$3.43M(m)$2.20M(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
STEPAN CO (SCL)United States$1.451B-477.05
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
ECOLAB INC. (ECL)United States$77.183B36.58
PROCTER & GAMBLE Co (PG)United States$338.763B21.26